Myocardial Injury Biomarkers in Newborns with Congenital Heart Disease
Troponin I, myoglobin, and creatine kinase-MB mass (CK-MB) are biomarkers of cardiomyocyte injury widely used in the management of adult patients. The role of these biomarkers in newborns is still not established. The purpose of this study was to evaluate the value of cardiac injury biomarkers in ne...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2016-12-01
|
| Series: | Pediatrics and Neonatology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1875957216300195 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850168620285427712 |
|---|---|
| author | Ana Luisa Neves Maria Cabral Adelino Leite-Moreira José Monterroso Carla Ramalho Hercília Guimarães Henrique Barros João T. Guimarães Tiago Henriques-Coelho José C. Areias |
| author_facet | Ana Luisa Neves Maria Cabral Adelino Leite-Moreira José Monterroso Carla Ramalho Hercília Guimarães Henrique Barros João T. Guimarães Tiago Henriques-Coelho José C. Areias |
| author_sort | Ana Luisa Neves |
| collection | DOAJ |
| description | Troponin I, myoglobin, and creatine kinase-MB mass (CK-MB) are biomarkers of cardiomyocyte injury widely used in the management of adult patients. The role of these biomarkers in newborns is still not established. The purpose of this study was to evaluate the value of cardiac injury biomarkers in newborns with congenital heart disease.
Methods: From August 2012 to January 2014, 34 newborns with a prenatal diagnosis of congenital heart disease were admitted consecutively to a neonatal intensive care unit. As controls, 20 healthy newborns were recruited. Plasma levels of cardiac biomarkers (troponin I, myoglobin, and CK-MB) were evaluated, and echocardiography was performed to evaluate cardiac function on D 1. Patients were followed during the first 28 days of life and, according to outcome, categorized as surgical or conservative treatment group.
Results: Median (P25–75) levels of CK-MB were higher in patients who underwent cardiac surgery in the neonatal period [7.35 (4.90–13.40) ng/mL] than in patients who were discharged home without surgery [4.2 (2.60–5.90) ng/mL; p = 0.032]. A CK-MB cutoff of ≥ 4.6 ng/mL showed sensitivity of 87.5% and specificity of 63.6%. Troponin I and myoglobin levels were not significantly different between conservative and surgical treatment groups. CK-MB levels correlated with the tissue Doppler image of the mitral valve lateral annulus peak early/late diastolic velocity ratio (ρ = −0.480, p = 0.018).
Conclusion: CK-MB levels during the first hours of life were higher in newborns that needed neonatal cardiac surgery, and these levels may be an indicator of myocardial diastolic function. |
| format | Article |
| id | doaj-art-a21496022df04522ae75a0d131bb80af |
| institution | OA Journals |
| issn | 1875-9572 |
| language | English |
| publishDate | 2016-12-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Pediatrics and Neonatology |
| spelling | doaj-art-a21496022df04522ae75a0d131bb80af2025-08-20T02:20:55ZengElsevierPediatrics and Neonatology1875-95722016-12-0157648849510.1016/j.pedneo.2015.11.004Myocardial Injury Biomarkers in Newborns with Congenital Heart DiseaseAna Luisa Neves0Maria Cabral1Adelino Leite-Moreira2José Monterroso3Carla Ramalho4Hercília Guimarães5Henrique Barros6João T. Guimarães7Tiago Henriques-Coelho8José C. Areias9Department of Paediatric Cardiology, São João Hospital, Porto, PortugalEPI Unit—Institute of Public Health, University of Porto, Porto, PortugalDepartment of Physiology and Cardiothoracic Surgery, Cardiovascular Research Centre, Faculty of Medicine, University of Porto, Porto, PortugalDepartment of Paediatric Cardiology, São João Hospital, Porto, PortugalDepartment of Physiology and Cardiothoracic Surgery, Cardiovascular Research Centre, Faculty of Medicine, University of Porto, Porto, PortugalDepartment of Physiology and Cardiothoracic Surgery, Cardiovascular Research Centre, Faculty of Medicine, University of Porto, Porto, PortugalDepartment of Physiology and Cardiothoracic Surgery, Cardiovascular Research Centre, Faculty of Medicine, University of Porto, Porto, PortugalDepartment of Physiology and Cardiothoracic Surgery, Cardiovascular Research Centre, Faculty of Medicine, University of Porto, Porto, PortugalDepartment of Paediatrics, Faculty of Medicine, University of Porto, Porto, PortugalDepartment of Paediatric Cardiology, São João Hospital, Porto, PortugalTroponin I, myoglobin, and creatine kinase-MB mass (CK-MB) are biomarkers of cardiomyocyte injury widely used in the management of adult patients. The role of these biomarkers in newborns is still not established. The purpose of this study was to evaluate the value of cardiac injury biomarkers in newborns with congenital heart disease. Methods: From August 2012 to January 2014, 34 newborns with a prenatal diagnosis of congenital heart disease were admitted consecutively to a neonatal intensive care unit. As controls, 20 healthy newborns were recruited. Plasma levels of cardiac biomarkers (troponin I, myoglobin, and CK-MB) were evaluated, and echocardiography was performed to evaluate cardiac function on D 1. Patients were followed during the first 28 days of life and, according to outcome, categorized as surgical or conservative treatment group. Results: Median (P25–75) levels of CK-MB were higher in patients who underwent cardiac surgery in the neonatal period [7.35 (4.90–13.40) ng/mL] than in patients who were discharged home without surgery [4.2 (2.60–5.90) ng/mL; p = 0.032]. A CK-MB cutoff of ≥ 4.6 ng/mL showed sensitivity of 87.5% and specificity of 63.6%. Troponin I and myoglobin levels were not significantly different between conservative and surgical treatment groups. CK-MB levels correlated with the tissue Doppler image of the mitral valve lateral annulus peak early/late diastolic velocity ratio (ρ = −0.480, p = 0.018). Conclusion: CK-MB levels during the first hours of life were higher in newborns that needed neonatal cardiac surgery, and these levels may be an indicator of myocardial diastolic function.http://www.sciencedirect.com/science/article/pii/S1875957216300195cardiac biomarkerscongenital heart diseaseechocardiographyoutcome |
| spellingShingle | Ana Luisa Neves Maria Cabral Adelino Leite-Moreira José Monterroso Carla Ramalho Hercília Guimarães Henrique Barros João T. Guimarães Tiago Henriques-Coelho José C. Areias Myocardial Injury Biomarkers in Newborns with Congenital Heart Disease Pediatrics and Neonatology cardiac biomarkers congenital heart disease echocardiography outcome |
| title | Myocardial Injury Biomarkers in Newborns with Congenital Heart Disease |
| title_full | Myocardial Injury Biomarkers in Newborns with Congenital Heart Disease |
| title_fullStr | Myocardial Injury Biomarkers in Newborns with Congenital Heart Disease |
| title_full_unstemmed | Myocardial Injury Biomarkers in Newborns with Congenital Heart Disease |
| title_short | Myocardial Injury Biomarkers in Newborns with Congenital Heart Disease |
| title_sort | myocardial injury biomarkers in newborns with congenital heart disease |
| topic | cardiac biomarkers congenital heart disease echocardiography outcome |
| url | http://www.sciencedirect.com/science/article/pii/S1875957216300195 |
| work_keys_str_mv | AT analuisaneves myocardialinjurybiomarkersinnewbornswithcongenitalheartdisease AT mariacabral myocardialinjurybiomarkersinnewbornswithcongenitalheartdisease AT adelinoleitemoreira myocardialinjurybiomarkersinnewbornswithcongenitalheartdisease AT josemonterroso myocardialinjurybiomarkersinnewbornswithcongenitalheartdisease AT carlaramalho myocardialinjurybiomarkersinnewbornswithcongenitalheartdisease AT herciliaguimaraes myocardialinjurybiomarkersinnewbornswithcongenitalheartdisease AT henriquebarros myocardialinjurybiomarkersinnewbornswithcongenitalheartdisease AT joaotguimaraes myocardialinjurybiomarkersinnewbornswithcongenitalheartdisease AT tiagohenriquescoelho myocardialinjurybiomarkersinnewbornswithcongenitalheartdisease AT josecareias myocardialinjurybiomarkersinnewbornswithcongenitalheartdisease |